argenx SE

-$1.01 (-0.34%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell argenx SE and other ETFs, options, and stocks.

About ARGX

argenx SE is a clinical-stage biotechnology company, which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include ARGX-113 for the treatment of autoimmune disease myasthenia gravis and ARGX-110 for the treatment of hematological cancer acute myeloid leukemia.

CEO
Tim van Hauwermeiren
Employees
336
Headquarters
Breda, Noord-Brabant
Founded
2008

ARGX Key Statistics

Market Cap
15.03B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
129.20K
High Today
$295.99
Low Today
$290.50
Open Price
$295.99
Volume
123.63K
52 Week High
$382.15
52 Week Low
$244.98

ARGX Earnings

-$4.42
-$2.29
-$0.15
$1.98
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
-$4.42 per share
Actual
Available Oct 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure